Sucrose ester stabilized solid lipid nanoparticles and nanostructured lipid carriers: I. Effect of formulation variables on the physicochemical properties, drug release and stability of clotrimazole-loaded nanoparticles

Nanotechnology

Volumn 25, Issue 10, 2014, Pages

  Das, Surajit ^a   Ng, Wai Kiong ^a,b   Tan, Reginald B H ^a,b  

^a INSTITUTE OF CHEMICAL AND ENGINEERING SCIENCES   (Singapore)

^b NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

clotrimazole; controlled release; nanostructured lipid carrier; solid lipid nanoparticle; sucrose ester

Indexed keywords

CLOTRIMAZOLE; DRUG CARRIER; ESTER; LIPID; NANOMATERIAL; NANOPARTICLE; SUCROSE;

ARTICLE; CHEMISTRY; MEDICINAL CHEMISTRY; METHODOLOGY; PARTICLE SIZE;

CHEMISTRY, PHARMACEUTICAL; CLOTRIMAZOLE; DRUG CARRIERS; ESTERS; LIPIDS; NANOPARTICLES; NANOSTRUCTURES; PARTICLE SIZE; SUCROSE;

EID: 84894117540     PISSN: 09574484     EISSN: 13616528     Source Type: Journal    
DOI: 10.1088/0957-4484/25/10/105101     Document Type: Article

References (29)

1. Muller R H, Mader K and Gohla S 2000 Solid lipid nanoparticles (SLN) for controlled drug delivery - a review of the state of the art Eur. J. Pharm. Biopharm. 50 161-77
2. Mehnert W and Mader K 2001 Solid lipid nanoparticles: production, characterization and applications Adv. Drug Deliv. Rev. 47 165-96
3. Pardeike J, Hommoss A and Muller R H 2009 Lipid nanoparticles (SLN, NLC) in cosmetic and pharmaceutical dermal products Int. J. Pharm. 366 170-84
4. Das S and Chaudhury A 2011 Recent advances in lipid nanoparticle formulations with solid matrix for oral drug delivery AAPS PharmSciTech 12 62-76
5. Müller R H 2007 Lipid nanoparticles: recent advances Adv. Drug Deliv. Rev. 59 375-6
6. Muller R H, Radtke M and Wissing S A 2002 Nanostructured lipid matrices for improved microencapsulation of drugs Int. J. Pharm. 242 121-8
7. Muller R H, Radtke M and Wissing S A 2002 Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) in cosmetic and dermatological preparations Adv. Drug Deliv. Rev. 54 S131-55
8. Das S, Ng W K and Tan R B H 2012 Are nanostructured lipid carriers (NLCs) better than solid lipid nanoparticles (SLNs): development, characterizations and comparative evaluations of clotrimazole-loaded SLNs and NLCs? Eur. J. Pharm. Sci. 47 139-51
9. Kovacevic A, Savic S, Vuleta G, Muller R H and Keck C M 2011 Polyhydroxy surfactants for the formulation of lipid nanoparticles (SLN and NLC): effects on size, physical stability and particle matrix structure Int. J. Pharm. 406 163-72
10. Souza L G, Silva E J, Martins A L, Mota M F, Braga R C, Lima E M, Valadares M C, Taveira S F and Marreto R N 2011 Development of topotecan loaded lipid nanoparticles for chemical stabilization and prolonged release Eur. J. Pharm. Biopharm. 79 189-96
11. Tiwari R and Pathak K 2011 Nanostructured lipid carrier versus solid lipid nanoparticles of simvastatin: comparative analysis of characteristics, pharmacokinetics and tissue uptake Int. J. Pharm. 415 232-43
12. Thevenin M A, Grossiord J L and Poelman M C 1996 Sucrose esters/cosurfactant microemulsion systems for transdermal delivery: assessment of bicontinuous structures Int. J. Pharm. 137 177-86
13. www.mfc.co.jp/english/, June 21, 2013
14. Li W, Das S, Ng K Y and Heng P W 2011 Formulation, biological and pharmacokinetic studies of sucrose ester-stabilized nanosuspensions of oleanolic acid Pharm. Res. 28 2020-33
15. Ullrich S, Metz H and Mader K 2008 Sucrose ester nanodispersions: microviscosity and viscoelastic properties Eur. J. Pharm. Biopharm. 70 550-5
16. Glatter O, Orthaber D, Stradner A, Scherf G, Fanun M, Garti N, Clement V and Leser M E 2001 Sugar-ester nonionic microemulsion: structural characterization J. Colloid Interface Sci. 241 215-25
17. Klang V, Matsko N, Zimmermann A M, Vojnikovic E and Valenta C 2010 Enhancement of stability and skin permeation by sucrose stearate and cyclodextrins in progesterone nanoemulsions Int. J. Pharm. 393 152-60
18. Takegami S, Kitamura K, Kawada H, Matsumoto Y, Kitade T, Ishida H and Nagata C 2008 Preparation and characterization of a new lipid nano-emulsion containing two cosurfactants, sodium palmitate for droplet size reduction and sucrose palmitate for stability enhancement Chem. Pharm. Bull. 56 1097-102
19. Arica Yegin B, Benoit J P and Lamprecht A 2006 Paclitaxel-loaded lipid nanoparticles prepared by solvent injection or ultrasound emulsification Drug Dev. Ind. Pharm. 32 1089-94
20. Paul B K and Mitra R K 2006 Percolation phenomenon in mixed reverse micelles: the effect of additives J. Colloid Interface Sci. 295 230-42
21. Honeywell-Nguyen P L, Frederik P M, Bomans P H, Junginger H E and Bouwstra J A 2002 Transdermal delivery of pergolide from surfactant-based elastic and rigid vesicles: characterization and in vitro transport studies Pharm. Res. 19 991-7
22. Lippacher A, Muller R H and Mader K 2002 Semisolid SLN dispersions for topical application: influence of formulation and production parameters on viscoelastic properties Eur. J. Pharm. Biopharm. 53 155-60
23. Kyle A A and Dahl M V 2004 Topical therapy for fungal infections Am. J. Clin. Dermatol. 5 443-51
24. Sawyer P R, Brogden R N, Pinder R M and Speight T M 1975 Avery, clotrimazole: a review of its antifungal activity and therapeutic efficacy Drugs 9 424-47
25. Laby R H 1985 Controlled release compositions for administration of therapeutic agents to ruminants US Patent Specification 4,671,789 A
26. www.montelloinc.com/dk- ester3.htm June 21, 2013
27. Das S, Ng W K, Kanaujia P, Kim S and Tan R B H 2011 Formulation design, preparation and physicochemical characterizations of solid lipid nanoparticles containing a hydrophobic drug: effects of process variables Colloids Surf. B 88 483-9
28. Chen C C, Tsai T H, Huang Z R and Fang J Y 2010 Effects of lipophilic emulsifiers on the oral administration of lovastatin from nanostructured lipid carriers: physicochemical characterization and pharmacokinetics Eur. J. Pharm. Biopharm. 74 474-82
29. Das S, Ng W K and Tan R B 2012 Development and ed G Tiddy and R B H Tan (London: NanoFormulation RSC) pp 38-52